Cumberland Pharmaceuticals (CPIX) Tax Provisions (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) reported Tax Provisions of $3871.0 for Q1 2026, down 31.73% on a YoY basis from $5670.0 in Q1 2025, and down 83.35% sequentially from $23245.0 in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Tax Provisions (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 17 years of Tax Provisions data on file, last reported at $3871.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 31.73% year-over-year to $3871.0; the trailing twelve-month figure through Mar 2026 stood at $38457.0 (up 235.22% YoY), and the FY2025 full-year result was $40256.0, up 277.58% from the prior year.
- Tax Provisions declined to $3871.0 in Q1 2026, from $23245.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $48150.0 in Q4 2022 to a low of -$56996.0 in Q4 2024.
- A 5-year average of $8004.5 and a median of $6937.0 in 2023 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions soared 284.71% in 2022 and sank 328.39% in 2024, its largest moves.
- Tracing CPIX's Tax Provisions over 5 years: stood at $48150.0 in 2022, then slumped by 48.17% to $24956.0 in 2023, then tumbled by 328.39% to -$56996.0 in 2024, then jumped by 140.78% to $23245.0 in 2025, then sank by 83.35% to $3871.0 in 2026.
- Business Quant data shows CPIX's Tax Provisions at $3871.0 in Q1 2026, $23245.0 in Q4 2025, and $5670.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 43.40 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Cumberland Pharmaceuticals | 99.04 Mn | 88.03 Mn | 7.20 Mn | 3,871.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,871.00 |
| Dec 31, 2025 | 23,245.00 |
| Sep 30, 2025 | 5,670.00 |
| Jun 30, 2025 | 5,671.00 |
| Mar 31, 2025 | 5,670.00 |
| Dec 31, 2024 | -56,996.00 |
| Sep 30, 2024 | 11,442.00 |
| Jun 30, 2024 | 11,443.00 |
| Mar 31, 2024 | 11,442.00 |
| Dec 31, 2023 | 24,956.00 |
| Sep 30, 2023 | 6,938.00 |
| Jun 30, 2023 | 6,937.00 |
| Mar 31, 2023 | 6,938.00 |
| Dec 31, 2022 | 48,150.00 |
| Sep 30, 2022 | 6,900.00 |
| Jun 30, 2022 | 6,900.00 |
| Mar 31, 2022 | 6,900.00 |
| Dec 31, 2021 | 12,516.00 |
| Sep 30, 2021 | 7,458.00 |
| Jun 30, 2021 | 7,459.00 |